Rexulti 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FAQBK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,042
Award facts
- Contract value 100% obligated
- $23,041.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of REXULTI 4 MG tablets (30-count units) under a firm fixed-price contract valued at approximately $23,000. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal pharmaceutical procurement requirements through open competition. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and related government medical supply chains. The company's extensive portfolio includes brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. REXULTI (brexpiprazole) is an atypical antipsychotic medication typically used in the treatment of schizophrenia and major depressive disorder, consistent with the company's role as a provider of neurological and psychiatric treatments to federal healthcare systems. The delivery order has an ultimate completion date of August 14, 2025, indicating expedited fulfillment requirements for this pharmaceutical supply.
Quick answers
Who was awarded contract SPE2DB25FAQBK?
SPE2DB25FAQBK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FAQBK worth?
The government has obligated $23,042 on SPE2DB25FAQBK.
Is contract SPE2DB25FAQBK an order under another contract?
Yes. SPE2DB25FAQBK is a delivery order under SPE2DB24D2105, an indefinite delivery contract.
Was contract SPE2DB25FAQBK competed?
The extent of competition for SPE2DB25FAQBK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award